About Us


Biomerica Reports Fiscal 2021 Year End Results

Posted: August 29, 2021 at 1:49 am

IRVINE, Calif., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2021 financial results. During the year the Company made significant progress in its business by increasing its number of allowed patents covering its InFoods® diagnostic guided therapy technology, signing a distribution agreement for its H. Pylori product which is expected to be filed with FDA in October, 2021, and has entered into negotiations with major retailers/distributors for sales of its EZ Detect colorectal disease test.

See the original post here:
Biomerica Reports Fiscal 2021 Year End Results

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.